RetinAI's Disease Evaluation Apps are advanced tools designed to enhance the management of retinal diseases in clinical settings. Integrated with Heidelberg's HEYEX 2 via the secure AppWay portal, these applications provide expert-level analysis of Optical Coherence Tomography (OCT) volumes. During a patient's visit, the apps generate detailed PDF reports that complement the evaluation and management of conditions such as Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Diabetic Macular Edema (DME), Cystoid Macular Edema (CME), and Geographic Atrophy (GA). By offering insights into disease status and biomarkers, these reports empower both clinicians and patients, facilitating informed decision-making and active participation in disease management.